Jeffrey A. Robl;Mark C. Manfredi;William N. Washburn;Andres S. Hernandez
发明人:
William N. Washburn,Mark C. Manfredi,Jeffrey A. Robl,Andres S. Hernandez
申请号：
US11586255
公开号：
US08618115B2
申请日:
2006.10.25
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I.
